Jonathan Green

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry et al. · Journal of Bone and Mineral Research · 2003 · 267 citations · Full text

A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden

Céline Le Gall, Akeila Bellahcène, Edith Bonnelye et al. · Cancer Research · 2007 · 198 citations · Full text

The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE)

Bei-Qing Pan, Amanda Farrugia, Luen Bik To et al. · Journal of Bone and Mineral Research · 2004 · 158 citations · Full text

High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity <i>In Vivo</i>

Ismahène Benzaïd, Hannu Mönkkönen, Verena Stresing et al. · Cancer Research · 2011 · 147 citations

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro

Bei-Qing Pan, Luen Bik To, Amanda Farrugia et al. · Bone · 2003 · 125 citations

Tissue Engineering, Zoledronic Acid, Bone Health +10